PHC Holdings Corporation (TYO:6523)
1,070.00
-4.00 (-0.37%)
Jul 15, 2026, 3:30 PM JST
PHC Holdings Revenue
In the fiscal year ending March 31, 2026, PHC Holdings had annual revenue of 364.40B JPY with 0.78% growth. PHC Holdings had revenue of 95.15B in the quarter ending March 31, 2026, with 0.50% growth.
Revenue
364.40B
Revenue Growth
+0.78%
P/S Ratio
0.37
Revenue / Employee
42.14M
Employees
8,647
Market Cap
136.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 364.40B | 2.81B | 0.78% |
| Mar 31, 2025 | 361.59B | 7.69B | 2.17% |
| Mar 31, 2024 | 353.90B | -2.53B | -0.71% |
| Mar 31, 2023 | 356.43B | 15.98B | 4.69% |
| Mar 31, 2022 | 340.45B | 34.38B | 11.23% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nihon Kohden | 235.10B |
| Fukuda Denshi | 139.70B |
| Japan Lifeline | 59.19B |
| DVx Inc. | 55.99B |
| Eiken Chemical | 41.90B |
| Seikagaku | 36.65B |
| Japan Medical Dynamic Marketing, INC. | 23.92B |
| Techno Medica | 11.24B |
PHC Holdings News
- 2 months ago - PHC Holdings Earnings Call Transcript: Q4 2026 - Transcripts
- 2 months ago - PHC Holdings Quarterly report: Q4 2026 - Filings
- 2 months ago - PHC Holdings Slides: Q4 2026 - Filings
- 5 months ago - Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics - Business Wire
- 5 months ago - PHC Holdings Earnings Call Transcript: Q3 2026 - Transcripts
- 5 months ago - PHC Holdings Quarterly report: Q3 2026 - Filings
- 5 months ago - PHC Holdings Slides: Q3 2026 - Filings
- 8 months ago - PHC Holdings Earnings Call Transcript: Q2 2026 - Transcripts